Predicting survival after whole-brain irradiation for cerebral metastases from prostate cancer

Tobias Bartscht, Dirk Rades*

*Corresponding author for this work
5 Citations (Scopus)

Abstract

Background/Aim: Prostate cancer patients represent a small minority of those presenting with cerebral metastases. Knowledge about overall survival (OS) contributes to individualization of treatment concepts. In this study an OS score was created for patients receiving whole-brain irradiation (WBI) for cerebral metastases from prostate cancer. Patients and Methods: Of six variables, four were significantly associated with OS: performance status, time from diagnosis of prostate cancer to WBI, number of cerebral lesions, extracranial metastases. Results: Six-month OS rates of the four variables (in %, divided by 10) were added. The addition resulted in scores of 1 to 19 points. Six-month OS rates were 0% for <15 points and 100% for ≥15 points (p<0.001). Conclusion: An OS score was generated specifically for patients with cerebral lesions from prostate cancer. For patients with <15 points, a short WBI regimen (5x4 Gy) should be used, for patients with ≥15 points a longer regimen seems appropriate.

Original languageEnglish
JournalAnticancer Research
Volume34
Issue number8
Pages (from-to)4357-4360
Number of pages4
ISSN0250-7005
Publication statusPublished - 01.08.2014

Fingerprint

Dive into the research topics of 'Predicting survival after whole-brain irradiation for cerebral metastases from prostate cancer'. Together they form a unique fingerprint.

Cite this